Lytix Biopharma awarded Nordic Stars 2014
Oslo Cancer Cluster member Lytix Biopharma is one of three biotech companies selected as Nordic Stars 2014. The prize is given to companies that the organizers of the Nordic Life Science Days sees as extra promising.
The Nordic Stars Awards have been established to shed some extra light on those companies Nordic Life Science Days see really showcase how innovative Nordic companies can be.
– This is a great honour, says Unni Hjelmaas, CEO at Lytix Biopharma. – We appreciate that we are noticed in an active Nordic market with many promising companies. To receive such an award makes us aware that others are watching us and gives us an extra motivation to prove that it is possible for innovative Nordic companies to succeed.
– With this price and the attention given to us we have a good basis for dialogue with potential partners. We are very grateful that professionals outside our company believe in what we do, said Knut Eidissen, Chairman of the Board of Lytix Biopharma
Lytix Biopharma:
Lytix Biopharma’s technology is based on nature’s own defense mechanism. The membranes of bacteria and cancer cells are destroyed. Our technology has the potential to meet two substantial medical challenges; treatment of infections regardless of resistance and cancer therapy that activates the patient`s own immune system. Lytix Biopharma’s strategy is to develop its drug candidates to Proof of Concept, and then bring in partners for the final stages of product development and commercialization. See www.lytixbiopharma.com.
Nordic Life Science Days:
Nordic Life Science Days is the Nordic region’s largest partnering conference for the global life science industry. The conference attracts leading decision-makers in the life science sector, including the bioengineering, pharmaceuticals and Med Tech segments, along with investors, research institutions, politicians and authorities. This year’s Nordic Life Science Days event is taking place in partnership with Oslo Cancer Cluster and Toulouse Cancer-Bio-Santé Cluster.
This year they have:
840+ registered delegates
570+ companies/organizations
26 countries represented
7000+ meeting requests in partneringONE
1400+ accepted meetings
480+ licensing opportunities
